Fasting serum fatty acid-binding protein 4 level positively correlates with metabolic syndrome in hemodialysis patients

Archives of Medical Research

Volumn 41, Issue 7, 2010, Pages 536-540

  Tsai, Jen Pi ^a   Liou, Hung Hsiang ^b   Liu, Hsiang Man ^a   Lee, Chung Jen ^d   Lee, Ru Ping ^c   Hsu, Bang Gee ^a,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b Hsin Jen Hospital   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

Author keywords

Fatty acid binding protein 4; Hemodialysis; Metabolic syndrome

Indexed keywords

ADIPONECTIN; CHOLESTEROL; CREATININE; FATTY ACID BINDING PROTEIN 4; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; FASTING; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RENAL DIALYSIS;

EID: 78650076493     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.09.007     Document Type: Article

References (29)

1. Chmurzyńska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006, 47:39-48.
2. Krusinova E., Pelikanova T. Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?. Diabetes Res Clin Pract 2008, 82(suppl 2):S127-S134.
3. Furuhashi M., Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008, 7:489-503.
4. Makowski L., Hotamisligil G.S. Fatty acid binding proteins: the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004, 134:2464S-2468S.
5. Makowski L., Hotamisligil G.S. The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr Opin Lipidol 2005, 16:543-548.
6. Boord J.B., Fazio S., Linton M.F. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 2002, 13:141-147.
7. Alberti K.G., Zimmet P.Z., Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
8. Scott C.L. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol 2003, 92:35i-42i.
9. Peralta C.A., Kurella M., Lo J.C., et al. The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2006, 15:361-365.
10. Yang S.Y., Chiang C.K., Hsu S.P., et al. Metabolic syndrome predicts hospitalization in hemodialysis patients: a prospective Asian cohort study. Blood Purif 2007, 25:252-259.
11. Stejskal D., Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?. Eur J Clin Invest 2006, 36:621-625.
12. Xu A., Wang Y., Xu J.Y., et al. Adipocyte fatty acid binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52:405-413.
13. Xu A., Tso A.W., Cheung B.M., et al. Circulating adipocyte fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007, 115:1537-1543.
14. Hsu B.G., Chen Y.C., Lee R.P., et al. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ J 2010, 74:327-331.
15. Lee C.C., Lee R.P., Subeq Y.M., et al. Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients. Arch Med Res 2008, 39:785-790.
16. Okano K., Ohba T., Matsugami K., et al. Analysis of plasma adipocytokines related to clinical and laboratory data in the maintenance hemodialysis patients. Intern Med 2008, 47:1379-1386.
17. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
18. Tsangalis G., Papaconstantinou S., Kosmadakis G., et al. Prevalence of the metabolic syndrome in hemodialysis. Int J Artif Organs 2007, 30:118-123.
19. Sommer G., Ziegelmeier M., Bachmann A., et al. Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis. Clin Endocrinol 2008, 69:901-905.
20. Cabré A., Lázaro I., Girona J., et al. Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin Chem 2008, 54:181-187.
21. Wierzbicki A.S., Graham C.A., Young I.S., et al. Familial combined hyperlipidaemia: under-defined and under-diagnosed?. Curr Vasc Pharmacol 2008, 6:13-22.
22. Cabre A., Lazaro I., Cofan M., et al. FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res 2010, 51:1173-1178.
23. Choi K.M., Kim T.N., Yoo H.J., et al. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrinol 2009, 70:569-574.
24. Oh D.K., Ciaraldi T., Henry R.R. Adiponectin in health and disease. Diabetes Obes Metab 2007, 9:282-289.
25. Wang J., Li H., Franco O.H., et al. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity 2008, 16:172-178.
26. Yun J.E., Sull J.W., Lee H.Y., et al. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes Metab Res Rev 2009, 25:259-265.
27. Karpisek M., Stejskal D., Kotolova H., et al. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia. Eur J Clin Invest 2007, 37:637-642.
28. Cabré A., Lázaro I., Girona J., et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007, 195:e150-e1508.
29. Rhee E.J., Lee W.Y., Park C.Y., et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 2009, 160:165-172.